The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...

The recall only affects the sensor component of the FreeStyle Libre 3 system, which also includes a reader and an app.

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...

Both of Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology, as Dexcom's prescription-free Stelo follows the popular G6 and G7 CGM technology for people who ...

[Harley] decided not to wait and managed to interface an Abbot FreeStyle Libre sensor with the Apple watch. The sensor doesn’t directly read glucose continuously, but it does allow for more ...

[Harley] decided not to wait and managed to interface an Abbot FreeStyle Libre sensor with the Apple watch. The sensor doesn’t directly read glucose continuously, but it does allow for more ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Pharmacies have been turning patients away as deliveries of healthcare firm Abbott's Freestyle Libre Sensor are delayed by two or three weeks. Abbott has said it is working hard to fulfil all the ...

Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 ...

Ltd. Boston Scientific (Bard® Stent System, Antibacterial Coating Technologies) Abbott Laboratories (Xience® Drug-Eluting ...

Some better-ranked stocks in the broader medical space are TransMedix Group TMDX, Veracyte VCYT and Boston Scientific BSX. While TransMedix Group and Veracyte currently sport a Zacks Rank #1 (Strong ...